학술논문

Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjogren Syndrome (CRESS) and Sjogren Tool for Assessing Response (STAR) to B Cell-Targeted Therapy in the Trial of Anti-B Cell Therapy in Patients With Primary Sjogren Syndrome (TRACTISS)